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Abstract
Background: Ischemia/reperfusion (IR) injury of the intestine is a 
major problem in abdominal pathological condition and is associ-
ated with a high morbidity and mortality. The purpose of the study 
is to determine whether the L-carnitine can prevent the harmful ef-
fects of small intestinal IR injury in rats.
Methods: Thirty Sprague-Dawley rats were randomly divided into 
three groups. Sham operated group (S), for sham–operated, the IR 
group for rats submitted to 45-minute of intestinal ischemia and 
2-hour reperfusion, and IR+L group for those IR group treated with 
L-carnitine before reperfusion. All the rats were given EmGFP la-
belled E. coli DH5α through gavage 2-hour before the operative 
procedure. Afterwards the bacterial translocation (BT) from mes-
enteric lymph nodes (MLN), liver, spleen, lung and portal vein 
blood were detected. And the colony forming units/g (CFU/g) were 
counted. The TNF-α, IL-1β, IL-6, and IL-10 in serum were mea-
sured by ELISA. The morphometric study was measured by Chiu’s 
classiﬁ  cation.
Results: The levels of BT were higher in the IR group than IR+L 
group (P < 0.05). The E. coli DH5α was hardly detected in the S 
group. The IR+L rats had enhancement of IL-10 and suppressed 
production of serum TNF-α, IL-1β and IL-6, compared to IR group 
rats (P < 0.05). The degree of pathological impairment in small in-
testine was lighter in IR+L than IR group (P < 0.05).
Conclusions: The L-carnitine pretreatment has a positive effect on 
reducing levels of BT, on inhibiting secretion of proinﬂ  ammatory 
cytokines, and on lessening intestinal mucosa injury during small 
intestinal IR injury.
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Introduction
The gastrointestinal tract is a tissue which is highly sensi-
tive to ischemia-reperfusion (IR) injury in the body [1]. The 
intestinal IR injury is caused by many clinical conditions, 
including acute mesenteric ischemia, intestinal obstruction, 
incarcerated hernia, small intestine transplantation, neona-
tal necrotizing enterocolitis, trauma, and shock [2-4]. It is 
extremely dangerous and emergent for patients to have in-
testinal IR injury because it may result in an array of severe 
clinical syndromes, and even death [5]. Under the normal 
physiological situation, the maintenance of bacteria and their 
products in the intestine depends on mucosal mucin and a 
layer of epithelial cells, and the unbroken intestinal barrier 
is essential for health and survival. In addition, the epithelial 
cells have high metabolism activity, and it is also susceptible 
to oxygen deprivation with subsequent ischemia damage to 
enterocytes and their supporting structures [6]. The impair-
ment of the intestinal barrier may lead to decrease in absorp-
tion of nutrition, and the bacteria in the intestine may trans-
locate to blood and other organs due to the damage of the 
intestinal barrier. The consequences of the bacterial translo-
cation (BT) and release of harmful substances produced by 
the bacteria into blood circulation are to activate inﬂ  amma-
tory mediators and initiate Systemic Inﬂ  ammatory Response 
(SIRS) or Multiorgan Dysfunction Syndrome (MODS) [7, 
8]. Thus, there is a great interest in exploring methods to 
protect the small intestine from lesions. L-carnitine is an im-
portant active material, which plays a crucial role in energy 
metabolism. The shortage of L-carnitine includes metabo-
lism disruption and induction of a series of disorders. Xie et 
al’s study has demonstrated that L-carnitine has a protective 
effect on IR injury, which is partly due to its prevention of 
energy loss and its antioxidant activity [9]. Moreover, it has 
a protective effect on oxidative stress-induced DNA dam-
age [10]. Oyanagi et al’s study [11] has demonstrated that 
L-carnitine can maintain mitochondrial function and sup-
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press oleic acid-mediated membrane permeability transition 
(MPT) of mitochondria through acceleration of beta-oxida-
tion. The opening of MPT has been proved as a key event 
in cell apoptosis or necrosis after IR injury [12, 13]. It has 
been suggested that L-carnitine would prevent apoptosis and 
maintain functions of cell. The purpose of this experiment 
is to explore the effects of L-carnitine on the rats suffering 
from the small intestinal IR injury through detecting translo-
cation of EmGFP labelled E. coli from the mesenteric lymph 
nodes, liver, spleen and portal vein blood. Additionally, the 
small intestinal morphometric study was performed and the 
levels of serum cytokines (TNF-α, IL-1β, IL-6 and IL-10) 
were investigated.
Materials and Methods
Animals
A total of thirty adult SD rats were obtained from the Ex-
perimental Research Center of Zhengzhou University, and 
their weight is in the range of 280 - 320 g. All of the rats 
were maintained under standard conditions with controlled 
temperature (18 ± 4 °C), 12 hours light and 12 hours dark-
ness cycle, and feeding with standard food and water. The 
maintenance of the experimental rats was administrated by 
licensed operators and these rats were given humane treat-
ment. This study was approved by the Ethical Committee of 
Kunming Medical University.
Labeling of Escherichia coli
The Escherichia coli DH5α (donated from PHD Cao, the De-
partment of Micro-organism of Kunming Medical Univer-
sity) was selected to label with EmGFP. The brief procedures 
are as follows. 1. Establishment of competent bacteria using 
CaCl2 method. 2. Transformation of plasmid DNA (pRSET-
EmGFP bought from the Invitrogen Company) into E. coli 
using the heat shock method. A mixture of the competent 
bacteria and the plasmid DNA were placed in iced bath for 
30 minutes and put at 42 °C for 2 minutes (heat shock), and 
then placed back into the iced bath. After transformation, the 
bacteria were cultured on Luria-Bertani plate with ampicil-
lin (100 mg/L) at 37 °C for 12 hours. Four colonies were 
inoculated into liquid media (200 ml) and grown at 37 °C 
with agitation for 16 hours in order to ensure growth of iso-
lated colonies. The E. coli DH5α with transformed plasmid 
containing EmGFP were detected by using ﬂ  uorescence mi-
Table 1. The Chiu’s Score Classiﬁ  cation of Small Intestinal Injury
Figure 1. The E. coli with GFP were detected with ﬂ  uores-
cence microscope. The cells displayed rod shape and erupt-
ed ﬂ  uorescent light.
Classiﬁ  cation Pathological change
Level 0 Mucosa without changes.
Level 1
Well-constituted villosities, no cellular lysis or inﬂ  ammatory process, although there is 
formation of Grunhagen’s sub-epithelial space.
Level 2
Presence of cellular lysis, formation of Grunhagen’s sub-epithelial space and increased 
spacing among the villosities.
Level 3 Destruction of the free villosities section, presence of dilated capillaries and inﬂ  amed cells.
Level 4
Structural destruction of the villosities, only traces of some villosities, formed by inﬂ  amed 
cells and necrotic material, with hemorrhage and basal glandular ulceration.
Level 5
Destruction of all the mucosa, no glandular structure can be seen, only the amorphous 
material laying on the sub-mucosa tissue.
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croscope (Fig. 1). The bacteria were cultured for the study to 
the density of 7.5 × 106/ml.
Intestinal IR injury model and operative procedures
The thirty healthy SD rats were randomly divided into three 
groups (n = 10 for each group): sham operated group (S), IR 
group (IR) and IR+L-carnitine group (IR+L). All of the ani-
mals were given the EmGFP labeled E. coli 2 ml by gavage 
two hours before surgical procedures. The rats were anes-
thetized through injecting Urethane 200 mg/kg into the peri-
toneal cavity. In the S group, the rats received a 3-centime-
ter medium-length-wise laparotomy, and the small intestine 
was exposed. Subsequently, the superior mesenteric artery 
(SMA) was identiﬁ  ed and dissected, and then the peritoneal 
cavity was closed. In the IR group, the rats underwent intes-
tinal ischemia for 45 minutes through occlusion of the SMA 
with a micro vascular clamp. The occluding clamp was re-
moved after ischemia for a reperfusion period for 2 hours. In 
the IR+L group, the rats were given intervention of intestinal 
ischemia, which was the same as that in the IR group, and 
they were injected L-caritine 80 mg/kg suspended in saline 
solution (total volume = 2 ml) through tail vein before re-
perfusion injury. Meanwhile, the rats were given 2 ml saline 
solution instead of L-caritine in both the S and IR groups.
At the end of the procedures, one milliliter venous sys-
temic serum was collected in order to measure the levels of 
TNF-α, IL-1β, IL-6 and IL-10 in venous blood using ELISA. 
The rats were sacriﬁ  ced and a one-centimeter segment of il-
eum was dissected and processed using standard histologi-
cal techniques including formalin ﬁ  xation, dehydration and 
parafﬁ  n embedding, and was subsequently cut into 4 μm 
sections and stained with Haematoxylin and Eosin. All of 
the sections were analyzed with an optic microscope by the 
pathologist who did not know which group each rat belonged 
to, and they were classiﬁ  ed according to the degree of tissue 
injury in accordance to Chiu’s score classiﬁ  cation [14] (Ta-
ble 1). The homogenate of the mesenteric lymph nodes, liv-
er, spleen, lung and half milliliter blood of portal vein were 
detected for the BT. Among the homogenate, 0.1 gram was 
cultured in agar culture media with ampicillin (100 mg/L) at 
37 °C for 24 hours in order to count the CFU/g of bacteria.
Statistical analysis
Data was presented as mean ± standard derivation (SD). 
One-way analysis of variance (ANOVA) and Tukey Post 
Hoc (parametric) test were used to compare serum cyto-
kines and translocation of bacteria between the three groups. 
Histopathologic grades of each group were compared using 
Groups n MLN Liver Lung Spleen Portal vein blood
S 10 1.2 ± 1.03Δ 0.0 ± 0.00Δ 0.0 ± 0.00Δ 0.0 ± 0.00Δ 2.0 ± 2.58Δ
IR 10 25.1 ± 3.41* 20.5 ± 3.03* 25.5 ± 3.92* 15.2 ± 3.01* 19.9 ± 3.70*
IR+L 10 11.3 ± 2.36 10.0 ± 2.58 10.8 ± 2.25 10.3 ± 3.43 9.3 ± 1.64
Table 2. The Levels of BT From MLN, Liver, Lung, Spleen and Portal Vein Blood (CFU/g) (Mean ± SD)
Δ P < 0.05 compared to IR and IR+L groups
* P < 0.05 compared to IR+L group
Figure 2. Normal intestinal mucosa in the S group rats 
(Grade 0) (H&E, × 100).
Figure 3. Intestinal villus after IR in group II rats, with lifted 
epithelium, white blood cells, and monocytes in the Lamina 
propria (Grade 4) (H&E, × 100).
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Kruskal-Wallis test and Tukey Post Hoc (nonparametric) 
test. The signiﬁ  cance level was established in P < 0.05 for 
all the tests.
Results
  
The levels of BT in different groups
The levels of BT had a signiﬁ  cant increase in animals dis-
tributed to the IR group, compared to animals in the IR+L-
carnitine and S groups (P < 0.05). In the S group, there were 
few colony forming units in culture plates of MLN and por-
tal vein blood (Table 2).
Changes of intestinal mucosa under light microscope
The villus and glands were normal and inﬂ  ammatory cell 
inﬁ  ltration was not observed in mucosal epithelial layer in 
the sham operated group (Fig. 2). Multiple erosions, inﬂ  am-
matory cells and bleeding were observed in the IR group 
(Fig. 3). Lighter edema of mucosa villus and fewer inﬁ  ltra-
tion of necrotic epithelial inﬂ  ammatory cells neutrophil leu-
komonocyte were found in mucosa epithelial layer in IR+L 
group than the IR group (Fig. 4).
Chiu’s score of small intestinal structure
In all of the three groups, the Chiu’s score was highest in the 
IR group, and it was lowest in the S group (P < 0.05). The 
score in the IR+L group was signiﬁ  cantly lower than that in 
the IR group (P < 0.05) (Table 3).
Changes in TNF-α and interleukins in vena systemic se-
rum
The concentrations of pro-inﬂ  ammatory factors including 
TNF-α, IL-1, and IL-6 in the experimental rats’ serum in 
the IR and IR+L group were higher than that in the S group 
(P < 0.05). And the levels of TNF-α, IL-1 and IL-6 in the 
IR group rats were higher than that in the IR+L group (P < 
0.05). The levels of inhibitive inﬂ  ammatory factor IL-10 in 
the IR+L group were lower than that in the IR group (P < 
0.05) (Table 4).
Discussion
  
The primary functions of the intestine are to absorb nutri-
ents and exclude food debris, bacteria and their products. 
The maintenance of these functions relies on the integrity 
of mucosal and barrier of intestine. However, under certain 
pathological circumstances such as intestinal IR injury, the 
intestine may lose its barrier function so that the systemic 
microbial infection, and even MODS could be induced [7]. 
Compared to other internal organs, the intestine is the organ 
that is most sensitive to IR injury in the body [15, 16]. There 
is increasing evidence from experimental and clinical stud-
ies to support the ‘intestinal hypothesis of sepsis’, which is 
based on bacterial or endotoxin translocation from the intes-
tinal lumen to the extra-intestinal sites [17]. Nevertheless, 
growing acceptance of the ‘intestinal hypothesis of sepsis’ 
was mainly triggered by indirect supports rather than con-
crete scientiﬁ  c evidence.
IR injury of the intestine is a complex, multifactorial, 
and pathophysiological process that involves the dysfunc-
tion of absorption, BT, actions of oxygen-derived free radi-
cals, cytokines, nitric oxide, and PMNs [18]. IR injury to the 
small intestine causes local production of the ROS, which 
is known to play an important role in gut epithelial damage 
[19]. Intestinal mucosal mast cells (IMMC) are particularly 
frequent in close proximity to epithelial surfaces, where they 
are strategically located for optimal interaction with the en-
vironment and for their putative functions of host defense 
[20]. Previous studies have demonstrated that the degranula-
tion of IMMC can be induced by oxidants generated in the 
post-ischemic gut, and the released inﬂ  ammatory mediators 
such as histamine and tumor necrosis factor-α (TNF-α) could 
aggravate the injury to intestine after reperfusion [21, 22]. In 
line with general IR-induced cell damage, also in intestinal 
Table 3. The Levels of Chiu’s Score in Small Intestinal 
Structure (Mean ± SD)
Δ P < 0.05 compared to IR and IR+L groups
* P < 0.05 compared to IR+L group
Figure 4. Development of Gruenhagen’s space at tip of a vil-
lus in group III rats (Grade 2) (H&E, × 100).
Groups n Small intestinal structure
S 10 0 ± 0.00Δ
IR 10 4.0 ± 0.41*
IR+L 10 2.4 ± 0.46
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IR, apoptosis is the major mode of cell death in the destruc-
tion of epithelial cells [23].
The intestinal IR injury can lead to mucosal cells en-
ergy exhaustion and is also associated with decrease in ATP 
synthesis [24-26]. Mitochondrium is one of the most impor-
tant organelle and regarded as a “dynamic factory”, and it is 
vulnerable to injury due to IR. Undoubtedly, the damage of 
mitochondria will induce energy exhaustion and failure of 
maintenance of cellular basic functions. The defective mi-
tochondrial oxidative phosphorylation and metabolic com-
promise play an important role in IR injury [27]. Increased 
ROS changes the mitochondrial membrane permeability and 
results in opening of mitochondrial permeability transition 
(MPT) [28]. The opening of MPT is a key event in cell death 
after ischemia-reperfusion [12, 13, 29]. Opening of the non-
speciﬁ  c mitochondrial permeability transition pore (mPTP) 
in the inner mitochondrial membrane results in the collapse 
of the membrane potential (Δψm), uncoupling of the respira-
tory chain, and efﬂ  ux of cytochrome c and other proapop-
totic factors that may lead to either apoptosis or necrosis 
[30]. Opening of the mPTP is triggered by Ca2+ overload and 
excessive production of ROS in the early minutes of reﬂ  ow, 
which is crucial event in reperfusion injury [31, 32]. Grifﬁ  ths 
and Halestrap’s study [33] have demonstrated that in isolated 
rat heart, the mPTP remained closure throughout ischemia 
but opened at the time of reperfusion.
L-Carnitine can carry long-chain fatty acylgroups into 
mitochondria for beta-oxidation. And it acts as a scavenger 
of oxygen free radical, relief of oxidative stress, and reduc-
tion of lipid peroxidation [34]. Therefore, L-Carnitine plays a 
protective role in metabolic disorders. Virmani and Gaetani’s 
study [35] revealed that L-carnitine could maintain the MPT 
and modulate the activation of the mitochondrial permeabil-
ity transition pores (mPTP), especially the cyclosporin-de-
pendent mPTP. Furthermore, their preliminary experiments 
also showed that LC may reduce the peroxynitrite levels and 
protect against the underlying mechanism of methamphet-
amine toxicity [36].
In this study, the hypothesis that enhancement of mi-
tochondrial energy metabolism by using L-carnitine could 
prevent the generation of inﬂ  ammatory factors and protect 
the integrality of mucosal barrier was tested. Moreover, the 
levels of TNF-α, IL-1β, IL-6, and IL-10 in serum (Table 4). 
The translocation of the E. Coli DH5α from extra-intestinal 
sites was examined in the study (Table 2) in order to obtain 
direct support for using L-carnitine that protects the intesti-
nal barrier.
In conclusion, the increase of L-carnitine density in IR 
intestine is a protective event. Mucosal injury and BT were 
reduced in the L-carnitine group, compared with the IR 
group (P less than 0.05). And L-carnitine effectively inhib-
ited releasing of pro-inﬂ  ammatory factors, compared with IR 
group (P less than 0.05). In addition, L-carnitine can protect 
intestine from IR injury because it can improve absorption of 
nutrients and prevention of BT. Nevertheless, clinical inves-
tigations will be required in order to conﬁ  rm the effective-
ness of L-carnitine as a therapeutic agent in clinical practice.
References
1.  Mojzis J, Hviscova K, Germanova D, Bukovicova D, 
Mirossay L. Protective effect of quercetin on ischemia/
reperfusion-induced gastric mucosal injury in rats. 
Physiol Res 2001;50(5):501-506.
2.  Mallick IH, Yang W, Winslet MC, Seifalian AM. Isch-
emia-reperfusion injury of the intestine and protective 
strategies against injury. Dig Dis Sci 2004;49(9):1359-
1377.
3.  Guneli E, Cavdar Z, Islekel H, Sarioglu S, Erbayraktar 
S, Kiray M, Sokmen S, et al. Erythropoietin protects the 
intestine against ischemia/ reperfusion injury in rats. 
Mol Med 2007;13(9-10):509-517.
4.  Teke Z, Kabay B, Aytekin FO, Yenisey C, Demirkan 
NC, Sacar M, Erdem E, et al. Pyrrolidine dithiocarba-
mate prevents 60 minutes of warm mesenteric ischemia/
reperfusion injury in rats. Am J Surg 2007;194(2):255-
262.
5.  Aldemir M, Gurel A, Buyukbayram H, Tacyildiz I. The 
effects of glucose-insulin-potassium solution and BN 
52021 in intestinal ischemia-reperfusion injury. Vasc 
Endovascular Surg 2003;37(5):345-351.
Groups n TNF-α IL-1 IL-6 IL-10
S 10 53.82 ± 8.94Δ 195.52 ± 52.26Δ 259.89 ± 89.41Δ 359.38 ± 76.32Δ
IR 10 575.02 ± 50.56* 601.29 ± 58.33* 567.25 ± 69.62* 126.06 ± 50.37*
IR+L 10 104.86 ± 10.61 291.58 ± 76.88 258.75 ± 77.58 254.65 ± 67.91
Table 4. The Levels of TNF-α and Interleukins in Arterial Serum (pg/ml)
Δ P < 0.05 compared to IR and IR+L groups
* P < 0.05 compared to IR+L group
82                                                                                                                                                                                                                         J Clin Med Res  •  2011;3(2):78-84 Yuan et al
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press™   |   www.jocmr.org
6.  Grotz MR, Ding J, Guo W, Huang Q, Deitch EA. Com-
parison of plasma cytokine levels in rats subjected to 
superior mesenteric artery occlusion or hemorrhagic 
shock. Shock 1995;3(5):362-368.
7.  Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hud-
son LD, Jurkovich GJ, Copass MK, et al. Outcome 
after hemorrhagic shock in trauma patients. J Trauma 
1998;45(3):545-549.
8.  Antonsson JB, Fiddian-Green RG. The role of the gut 
in shock and multiple system organ failure. Eur J Surg 
1991;157(1):3-12.
9.  Xie J, Zeng Q, Wang L. The protective effect of L-carni-
tine on ischemia-reperfusion heart. J Huazhong Univ Sci 
Technolog Med Sci 2006;26(2):188-191.
10. Berni A, Meschini R, Filippi S, Palitti F, De Amicis A, 
Chessa L. L-carnitine enhances resistance to oxidative 
stress by reducing DNA damage in Ataxia telangiectasia 
cells. Mutat Res 2008;650(2):165-174.
11.  Oyanagi E, Yano H, Kato Y, Fujita H, Utsumi K, Sasaki 
J. L-Carnitine suppresses oleic acid-induced membrane 
permeability transition of mitochondria. Cell Biochem 
Funct 2008;26(7):778-786.
12. Duchen MR, McGuinness O, Brown LA, Crompton M. 
On the involvement of a cyclosporin A sensitive mito-
chondrial pore in myocardial reperfusion injury. Cardio-
vasc Res 1993;27(10):1790-1794.
13. Grifﬁ  ths EJ, Halestrap AP. Protection by Cyclosporin A 
of ischemia/reperfusion-induced damage in isolated rat 
hearts. J Mol Cell Cardiol 1993;25(12):1461-1469.
14. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. 
Intestinal mucosal lesion in low-ﬂ  ow states. I. A mor-
phological, hemodynamic, and metabolic reappraisal. 
Arch Surg 1970;101(4):478-483.
15.  Granger DN, Hollwarth ME, Parks DA. Ischemia-reper-
fusion injury: role of oxygen-derived free radicals. Acta 
Physiol Scand Suppl 1986;548:47-63.
16. Yamamoto S, Tanabe M, Wakabayashi G, Shimazu 
M, Matsumoto K, Kitajima M. The role of tumor ne-
crosis factor-alpha and interleukin-1beta in ischemia-
reperfusion injury of the rat small intestine. J Surg Res 
2001;99(1):134-141.
17. Ceppa EP, Fuh KC, Bulkley GB. Mesenteric hemody-
namic response to circulatory shock. Curr Opin Crit 
Care 2003;9(2):127-132.
18.  Carden DL, Granger DN. Pathophysiology of ischaemia-
reperfusion injury. J Pathol 2000;190(3):255-266.
19.  Park PO, Haglund U, Bulkley GB, Falt K. The sequence 
of development of intestinal tissue injury after strangula-
tion ischemia and reperfusion. Surgery 1990;107(5):574-
580.
20. Penissi AB, Rudolph MI, Piezzi RS. Role of mast 
cells in gastrointestinal mucosal defense. Biocell 
2003;27(2):163-172.
21. Andoh A, Fujiyama Y, Araki Y, Kimura T, Tsujikawa 
T, Bamba T. Role of complement activation and mast 
cell degranulation in the pathogenesis of rapid intestinal 
ischemia/reperfusion injury in rats. Digestion 2001;63 
Suppl 1:103-107.
22.  Boros M, Ordogh B, Kaszaki J, Nagy S. The role of mast 
cell degranulation in ischaemia-reperfusion-induced 
mucosal injury in the small intestine. Ann Acad Med 
Singapore 1999;28(1):79-84.
23.  Ikeda H, Suzuki Y, Suzuki M, Koike M, Tamura J, Tong 
J, Nomura M, et al. Apoptosis is a major mode of cell 
death caused by ischaemia and ischaemia/reperfusion in-
jury to the rat intestinal epithelium. Gut 1998;42(4):530-
537.
24.  Kuenzler KA, Pearson PY, Schwartz MZ. Interleukin-11 
enhances intestinal absorptive function after ischemia-
reperfusion injury. J Pediatr Surg 2002;37(3):457-459.
25. Prasad R, Alavi K, Schwartz MZ. GLP-2alpha ac-
celerates recovery of mucosal absorptive function 
after intestinal ischemia/reperfusion. J Pediatr Surg 
2001;36(4):570-572.
26. Rajeevprasad R, Alavi K, Schwartz MZ. Glucagonlike 
peptide-2 analogue enhances intestinal mucosal mass 
and absorptive function after ischemia-reperfusion in-
jury. J Pediatr Surg 2000;35(11):1537-1539.
27. Jassem W, Fuggle SV, Rela M, Koo DD, Heaton ND. 
The role of mitochondria in ischemia/reperfusion injury. 
Transplantation 2002;73(4):493-499.
28. Tsujimoto Y, Shimizu S. Role of the mitochondrial 
membrane permeability transition in cell death. Apopto-
sis 2007;12(5):835-840.
29. Nazareth W, Yafei N, Crompton M. Inhibition of anox-
ia-induced injury in heart myocytes by cyclosporin A. J 
Mol Cell Cardiol 1991;23(12):1351-1354.
30.  Bernardi P, Petronilli V. The permeability transition pore 
as a mitochondrial calcium release channel: a critical ap-
praisal. J Bioenerg Biomembr 1996;28(2):131-138.
31. Piper HM, Meuter K, Schafer C. Cellular mecha-
nisms of ischemia-reperfusion injury. Ann Thorac Surg 
2003;75(2):S644-648.
32. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P. 
Opening of the mitochondrial permeability transition 
pore causes depletion of mitochondrial and cytosolic 
NAD+ and is a causative event in the death of myocytes 
in postischemic reperfusion of the heart. J Biol Chem 
2001;276(4):2571-2575.
33. Grifﬁ  ths EJ, Halestrap AP. Mitochondrial non-speciﬁ  c 
pores remain closed during cardiac ischaemia, but open 
upon reperfusion. Biochem J 1995;307( Pt 1):93-98.
34.  Augustyniak A, Skrzydlewska E. L-Carnitine in the lipid 
and protein protection against ethanol-induced oxidative 
stress. Alcohol 2009;43(3):217-223.
35.  Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. Possi-
ble mechanism for the neuroprotective effects of L-car-
nitine on methamphetamine-evoked neurotoxicity. Ann 
                                                                                                                                                                                                                       83J Clin Med Res  •  2011;3(2):78-84     L-Carnitine in Intestinal Ischemia/Reperfusion Injury
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press™   |   www.jocmr.org
N Y Acad Sci 2003;993:197-207; discussion 287-198.
36. Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. The 
protective role of L-carnitine against neurotoxicity 
evoked by drug of abuse, methamphetamine, could be 
related to mitochondrial dysfunction. Ann N Y Acad Sci 
2002;965:225-232.
84                                                                                                                                                                                                                         